Bioxcel Therapeutics Inc
BTAIQ·Stocks·Biotechnology·United States·OTC Markets Stock Exchange·USD
Price
$0.05
Today
-9.8%
YTD
-97.0%
About
BioXcel Therapeutics is a clinical-stage biopharmaceutical enterprise based in New Haven, Connecticut. It focuses on therapeutics in neuroscience and immuno-oncology. Established in 2017, the company operates locally in the US as a subsidiary of BioXcel. It trades under the BTAI ticker on the NASDAQ CM. Expand your investment portfolio with BTAI stock.
Price chart
Closing price history for BTAIQ (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.01
P/S (TTM)2.12
P/B (TTM)-0.01
Market cap$1.63M
Cap tierMicro-cap
Industry avg P/E-2.03
Profitability
Gross margin22.78%
EBIT margin-5970.89%
Net margin-8084.07%
ROE-1766.94%
ROA-259.62%
Earnings & Revenue
Revenue (TTM)$742,000.00
Revenue growth (1Y)-14.5%
EPS (TTM)-$4.23
Free cash flow$-50.90M
Total debt$104.45M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)2.04
Employees29
Next earnings26 Mar '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.